John Kauh, M.D.

John Kauh, M.D.

Chief Medical OfficeratTvardi Therapeutics· In proxies 2024–2025

Pay in FY2025Tvardi Therapeutics stock -76.6% the same year

John Kauh, M.D. was paid $1.2M in FY2025 (Dec). Tvardi Therapeutics stock fell 76.6% that year.

Pay$100 in the stock at the end of FY24 → $23
Pay is from the Summary Compensation Table of each Tvardi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tvardi TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role -96%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?